retatrutide sleep side effects vs. Tirzepatide: Dual vs. Triple Action, Doses, Benefits, Retatrutide side effects: What to

The maximum approved dose may be different if retatrutide is licensed in the future

Compounded semaglutide is a GLP-1 receptor agonist prepared by U.S.-licensed compounding pharmacies in accordance with applicable federal and state regulations

Microdosing, by contrast, involves maintaining doses below these established starting points or progressing more slowly than recommended

As of April 2025, retatrutide has not received MHRA marketing authorisation and is not available on the NHS

[3] It is not approved by NICE, nor is it available through NHS prescribing pathways

If you need more, you should either supplement with your own resources or consider a platform that includes coaching